ARQT

Arcutis Biotherapeutics, Inc. Common Stock
Data: 2026-08-21
$25.08
Price
-1.07%
Change
$31.77
52W High
$15.10
52W Low

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Quick Stats
Aug 21, 2026

58.4

AI Score

HOLD

1.4

Volume Ratio

TBA

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

ARQT Stock Summary

Last updated Aug 21, 2026

ARQT is currently trading at $25.08, positioned below its 200-day moving average of $25.6, suggesting bearish momentum. The stock has a 52-week range of $15.1 to $31.77.

Technical Analysis: The 50-day moving average stands at $26.71, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.513, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.132, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ARQT at 58.4/100 with a HOLD recommendation.

ARQT (Arcutis Biotherapeutics, Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 41.513
CMF (20) -0.132
ROC (10) -0.83
ADX (14) 18.246
Indicator Value
MACD (12,26,9) -0.264
AROONOSC (14) -71.429
WILLAMS %R (14) -88.323
MFI (14) 36.569
ARQT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ARQT Price vs Max Options Open Interest
ARQT Max Change In Options Open Interest

ARQT Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ARQT Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ARQT Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ARQT Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Arcutis Biotherapeutics, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

ARQT Moving Averages Analysis

ARQT (Arcutis Biotherapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 25.95
20 26.46
30 26.85
50 26.71
100 24.64
200 25.6

ARQT Fundamental Analysis

P/E (Forward) 60.241
P/E (Trailing) 120.7143
Market Cap ($) 3.2 billion
Earnings/Share ($) 0.21
Net Profit Margin (%) 0.0615
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.4117
EPS Estimate Next Year ($) 1.3033
WallStreet Target Price ($) 36.88
Most Recent Quarter